IRIS
BURLONE, MICHELA Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.678
NA - Nord America 1.443
AS - Asia 967
SA - Sud America 168
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.406
RU - Federazione Russa 418
IE - Irlanda 301
SG - Singapore 267
CN - Cina 237
DE - Germania 195
IT - Italia 174
SE - Svezia 144
FR - Francia 139
VN - Vietnam 136
BR - Brasile 129
HK - Hong Kong 125
UA - Ucraina 103
IN - India 85
FI - Finlandia 52
GB - Regno Unito 51
KR - Corea 25
AT - Austria 24
CA - Canada 22
AR - Argentina 18
ID - Indonesia 18
BE - Belgio 16
PL - Polonia 14
BD - Bangladesh 13
MX - Messico 13
ES - Italia 12
NL - Olanda 12
BJ - Benin 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 9
TR - Turchia 8
EC - Ecuador 7
JP - Giappone 7
IQ - Iraq 6
IR - Iran 6
KE - Kenya 5
PH - Filippine 5
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
JO - Giordania 3
PY - Paraguay 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
EU - Europa 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.292
Salva come PNG Salva come JPEG
Città #
Dublin 298
Jacksonville 176
San Jose 161
Hong Kong 125
Ashburn 111
Singapore 106
Chandler 89
Dearborn 82
Beijing 78
Ann Arbor 67
Wilmington 54
Moscow 42
Los Angeles 41
Piemonte 39
Ho Chi Minh City 37
Novara 36
Lauterbourg 34
Princeton 34
Lawrence 33
Munich 33
Hanoi 27
Buffalo 26
Seoul 25
Council Bluffs 22
Santa Clara 21
São Paulo 20
Frankfurt am Main 18
San Mateo 18
Brussels 16
New York 15
Andover 14
Milan 13
Nuremberg 13
Helsinki 12
Jakarta 12
Cotonou 11
Houston 11
Denver 10
Dong Ket 10
Brooklyn 9
Nanjing 9
Turin 9
Amsterdam 8
Atlanta 8
Brno 8
Dallas 8
Falkenstein 8
Hefei 8
Warsaw 8
Bremen 7
Da Nang 7
Guangzhou 7
London 7
Mumbai 7
Orem 7
Phoenix 7
Rome 7
Seattle 7
Johannesburg 6
Poplar 6
Redondo Beach 6
Tianjin 6
Tokyo 6
Toronto 6
Vienna 6
Ankara 5
Augusta 5
Bexley 5
Hangzhou 5
Jinan 5
Kunming 5
Manchester 5
Montreal 5
Nairobi 5
Porto Alegre 5
Stockholm 5
Biên Hòa 4
Boardman 4
Boston 4
Chicago 4
Curitiba 4
Dhaka 4
Hillsboro 4
Hải Dương 4
Leawood 4
Mexico City 4
Monmouth Junction 4
Rio de Janeiro 4
Shanghai 4
Turku 4
Woodbridge 4
Amman 3
Baku 3
Brasília 3
Calgary 3
Cassano Magnago 3
Chennai 3
City of London 3
Fairfield 3
Guayaquil 3
Totale 2.320
Salva come PNG Salva come JPEG
Nome #
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 156
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 155
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 152
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 136
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 133
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 132
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 131
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 127
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 125
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 123
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 122
Influence of age on sex-related differences among patients with hepatitis C. 119
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 114
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy] 114
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 113
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 112
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 112
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 111
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 108
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 108
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 107
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 105
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 103
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 103
Recent advances in HCV entry 99
Interferon-stimulated gene pathways in the treatment of viral hepatitis 97
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 93
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 92
The albumin–bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development 92
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study 89
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. 88
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 85
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 85
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 79
Toxocara encephalitis presenting with autonomous nervous system involvement 78
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 77
From MASH to HCC: the role of Gas6/TAM receptors 69
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 69
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 67
PANCREATOBILIARY REFLUX RESULTING IN PANCREATIC ASCITES AND CHOLEPERITONEUM AFTER GALLBLADDER PERFORATION 66
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 56
Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis 55
Totale 4.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.790
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 11 35 14
2021/2022234 4 13 31 18 15 2 20 12 16 22 32 49
2022/2023641 60 33 41 7 44 62 17 36 307 1 23 10
2023/2024240 24 39 21 0 35 2 42 6 1 4 27 39
2024/2025537 17 3 41 7 17 32 58 51 128 57 17 109
2025/20261.815 98 91 121 321 184 139 277 306 154 124 0 0
Totale 4.357